HAO-472

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameHAO-472
Drug Alias NameHAO-472
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsLeukemia, Myeloid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Hengrui Medicine Co LtdShanghai Jiaotong University
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Hengrui Pharmaceutical Co LtdJiangsu Hengrui Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A